Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening

Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening

Human papillomavirus (HPV) testing is replacing cytological screening for cervical cancer. Our aim was to assess the expected benefits and harms of different cervical screening strategies. This study is sub-analysis of a previous cost-effectiveness study with a target population of unscreened women...

Full description

Bibliographic Details
Main Authors:	Rosa Catarino, Pierre Vassilakos, Patrick Petignat, Christophe Combescure
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	Preventive Medicine Reports
Subjects:	Cervical cancer screening Developed countries Harms HPV testing Screening frequency Self-HPV
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211335522002364

Similar Items

Cervical cancer screening in Switzerland: time to rethink the guidelines
by: Pierre Vassilakos, et al.
Published: (2015-02-01)

How to improve cervical cancer screening in Switzerland?
by: Patrick Petignat, et al.
Published: (2012-08-01)

HPV-negative CIN3 and cervical cancer in Switzerland: any evidence of impact on screening policies?
by: Pierre Vassilakos, et al.
Published: (2017-11-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland
by: Fargnoli V, et al.
Published: (2015-11-01)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
by: Francisco I. Torres-Rojas, et al.
Published: (2021-06-01)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)

HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT
by: Clare Gilham, et al.
Published: (2019-06-01)

HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
by: Sunyoung Choi, et al.
Published: (2023-02-01)

HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot Study
by: Erin Vink, et al.
Published: (2024-07-01)

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study
by: Flores Yvonne, et al.
Published: (2002-01-01)

Improving cervical cancer screening in Mexico: results from the Morelos HPV Study
by: Flores Yvonne, et al.
Published: (2003-01-01)

“Easy women get it”: pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program
by: Rachel M. Morse, et al.
Published: (2023-12-01)

High-risk HPV Prevalence Estimates among Older Patients: Implications for Cervical Cancer Screening Programs
by: Sneha Mittal, et al.
Published: (2024-07-01)

From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening—A Historical Outline of Cervical Carcinoma and Its Relation to HPV Infection
by: Leonard Jung, et al.
Published: (2024-02-01)

High-risk HPV test in cervical cancer prevention – present and future
by: Natalia Zarankiewicz, et al.
Published: (2020-09-01)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
by: Angela Pista, et al.
Published: (2019-02-01)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
by: Guzhalinuer Abulizi, et al.
Published: (2021-12-01)

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context
by: Arianis Tatiana Ramírez, et al.
Published: (2023-10-01)

High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program
by: K. Torres-Poveda, et al.
Published: (2019-12-01)

How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study
by: Mie Sara Hestbech, et al.
Published: (2016-08-01)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
by: Alice Avian, et al.
Published: (2022-05-01)

Implementing HPV-DNA screening as primary cervical cancer screening modality in Zimbabwe: Challenges and recommendations
by: Grant Murewanhema, et al.
Published: (2023-09-01)

HPV self-sampling in the follow-up of women after treatment of cervical intra-epithelial neoplasia: A prospective study in a high-income country
by: Manuela Viviano, et al.
Published: (2021-12-01)

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
by: Zhi-Fang Li, et al.
Published: (2022-11-01)

The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study
by: Claire Bavor, et al.
Published: (2023-10-01)

Modern trends in the prevention of cervical cancer using screening programs (review)
by: S O Dubrovina
Published: (2015-12-01)

Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women
by: Chantal Sauvageau, et al.
Published: (2021-11-01)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018-06-01)

Do they cope or mope? A survey of GPs’ experiences with the changes in the Norwegian Cervical Cancer Screening Programme
by: Sofie Afseth, et al.
Published: (2022-07-01)

Cervical cancer screening in low-resource settings: a smartphone image application as an alternative to colposcopy
by: Gallay C, et al.
Published: (2017-06-01)

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
by: Clare A. Aitken, et al.
Published: (2019-12-01)

Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders’ perspectives
by: Fitriana Murriya Ekawati, et al.
Published: (2024-02-01)

Questionnaire survey on cervical cancer screening and HPV awareness among patients at a local cancer center in Japan
by: Kazuto Nakamura, et al.
Published: (2024-07-01)

Human Papillomavirus Infection in Partners of Women Attending Cervical Cancer Screening: A Pilot Study on Prevalence, Distribution, and Potential Use of Vaccines
by: Arianna Sucato, et al.
Published: (2025-02-01)

High-Risk HPV Screening Initiative in Kosovo—A Way to Optimize HPV Vaccination for Cervical Cancer
by: Jessica L. Bentz, et al.
Published: (2024-08-01)

Cervical cancer in Nepal: Current screening strategies and challenges
by: Mohan Narasimhamurthy, et al.
Published: (2022-11-01)

Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results
by: Anne Lesack, et al.
Published: (2022-05-01)

Human Papillomavirus (HPV) test and Pap Smear in Screening for Cervical Cancer: A systematic review on systematic review study
by: Amir Nejati, et al.
Published: (2020-09-01)